ADVFN Logo
Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
CERo Therapeutics Holdings Inc

CERo Therapeutics Holdings Inc (CERO)

0.0567
-0.0129
(-18.53%)
Closed December 14 4:00PM
0.061
0.0043
(7.58%)
After Hours: 7:59PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
0.061
Bid
0.06
Ask
0.30
Volume
31,559,266
0.0553 Day's Range 0.070199
0.05655 52 Week Range 12.38
Previous Close
0.0696
Open
0.068001
Last Trade Time
Average Volume (3m)
71,171,933
Financial Volume
$ 1,836,020
VWAP
0.058177

CERO Latest News

CERo Therapeutics, Inc. Appoints Chris Ehrlich CEO

SOUTH SAN FRANCISCO, Calif, Dec. 06, 2024 (GLOBE NEWSWIRE) --   CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Receives FDA Clearance of Investigational New Drug Application to Initiate Phase 1 Clinical Trial of Its Lead Compound CER-1236 in Acute Myelogenous Leukemia

SOUTH SAN FRANCISCO, Calif, Nov. 15, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next...

CERo Therapeutics, Inc. Presents Preclinical Data Demonstrating CER-1236 Killing Ovarian Cancer Cell Lines Without Toxicity

Data presented as part of a poster at the SITC 2024 Conference SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an...

CERo Therapeutics, Inc. Provides Corporate Update

Company announces submission of IND Clinical Hold Complete Response Letter SOUTH SAN FRANCISCO, Calif., Oct. 21, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer

SOUTH SAN FRANCISCO, Calif, Oct. 02, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation...

CERo Therapeutics, Inc. Announces Financing and Provides Update on Investigational New Drug Application for CER-1236

Company requests Type A Meeting with U.S. Food and Drug Administration regarding clinical hold for CER-1236; announces key management changes SOUTH SAN FRANCISCO, Calif., Sept. 25, 2024 (GLOBE...

CERo Therapeutics, Inc. Presents CER-1236 Data Supporting Use in AML at Global Cell & Gene Therapy Summit 2024

Company anticipates initial human trials to focus on AML upon IND clearance SOUTH SAN FRANCISCO, Calif., July 08, 2024 (GLOBE NEWSWIRE) --  CERo Therapeutics Holdings, Inc. (Nasdaq: CERO...

CERo Therapeutics, Inc. Completes IND-Enabling Activities Following Successful Manufacturing Runs for Lead Compound CER-1236

Company anticipates near term filing of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 13, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq:...

CERo Therapeutics, Inc. Successfully Completes IND-Enabling Toxicology Studies for Lead Compound CER-1236

Company continuing IND-enabling activities in preparation for submission of Investigational New Drug Application to FDA SOUTH SAN FRANCISCO, Calif., June 06, 2024 (GLOBE NEWSWIRE) --  CERo...

CERo Therapeutics, Inc. Provides Corporate Update for Shareholders

SOUTH SAN FRANCISCO, Calif., May 15, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq:CERO) (“CERo”) an innovative immunotherapy company seeking to advance the next generation...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1-0.113-64.94252873560.1740.180.05655206145000.09573525CS
4-0.272-81.68168168170.3330.44770.05655751934240.26195211CS
12-0.026-29.88505747130.0870.44770.05655711719330.22141088CS
26-0.859-93.36956521740.920.98580.05655363450520.22108211CS
52-5.189-98.83809523815.2512.380.05655224351860.26329237CS
156-5.189-98.83809523815.2512.380.05655224351860.26329237CS
260-5.189-98.83809523815.2512.380.05655224351860.26329237CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
WKEYWISeKey International Holdings AG
$ 7.84
(139.02%)
75.53M
IPHAInnate Pharma SA
$ 3.00
(93.55%)
13.59M
AVLDirexion Daily AVGO Bull 2X Shares
$ 33.67
(48.92%)
658.55k
LOOPLoop Industries Inc
$ 1.8092
(47.09%)
82.56M
AVGXDefiance Daily Target 2X Long AVGO ETF
$ 31.49
(46.67%)
3.55M
RPTXRepare Therapeutics Inc
$ 1.765
(-55.54%)
4.59M
INOInovio Pharmaceuticals Inc New
$ 2.31
(-38.56%)
9.59M
XXII22nd Century Group Inc
$ 0.048
(-34.69%)
41.72M
FLGCFlora Growth Corporation
$ 1.30
(-34.34%)
4.01M
WTOUTime Limited
$ 0.281
(-32.74%)
3.79M
NVDANVIDIA Corporation
$ 134.25
(-2.25%)
228.17M
SOUNSoundHound AI Inc
$ 16.905
(23.66%)
158.74M
TRUGTruGolf Holdings Inc
$ 0.6794
(30.93%)
138.19M
RGTIRigetti Computing Inc
$ 7.155
(19.85%)
122.67M
AVGOBroadcom Inc
$ 224.80
(24.43%)
117.74M

CERO Discussion

View Posts
georgie18 georgie18 15 hours ago
CERO...Took a loss here...All Out...Will watch for the Reverse Split...🥳
👍️0
pinkslipjunkie pinkslipjunkie 1 day ago
Or even yet they may be able to file for another 180-day extension beyond January 25, 2025 if they are granted from hearing panel.
👍️0
pinkslipjunkie pinkslipjunkie 2 days ago
No I found it, R/S has been voted in...after looking again in the 10Q a little harder....and just because it hasn't been activated on Dec 2 that it won't happen...could be any day now until January 15, 2025...they may hold off as long as they can before their 180 day extension is up to become compliant again.

8-K about the compliance 180 days: https://www.otcmarkets.com/filing/html?id=17917292&guid=T8Y-kWV46v3Th3h

10-Q filing: https://www.otcmarkets.com/filing/html?id=17988358&guid=T8Y-kWV46v3Th3h



NOTE 12 – Subsequent Events



On October 1, 2024, the Company’s Board of Directors granted Directors and Officers options to purchase up to 4.5 million shares of common stock for $0.10 per share. The grants have various vesting conditions, including time-based and performance-based terms. Additionally, on October 1, 2024, the exercise price of all other outstanding options granted under the 2024 Plan was adjusted to $0.10 per share, with all other terms of the original grant to remain without adjustment.



On October 23, 2024, the trading price for CERo common stock closed under $0.10 and was the tenth consecutive trading day to do so. On October 24, 2024, the Company received letter from the staff at The Nasdaq Global Market (“Nasdaq”) notifying the Company that, because its Common Stock had a closing bid price of $0.10 or less for ten consecutive trading days, it was no longer eligible to rely upon the 180-day cure period that commenced when the Company received notice in July 2024 that the closing bid price was below $1.00 for ten consecutive trading days and was scheduled to expire on January 15, 2025. In addition, on October 30, 2024, the Company received a letter from the staff at Nasdaq notifying the Company that it had not regained compliance with the continued listing requirement to maintain a minimum market value of $50,000,000 for its listed securities within the 180-day compliance period granted by Nasdaq in May 2024. Each such deficiency results in the commencement of delisting proceedings. However, the Company has requested a hearing from Nasdaq and plans to submit a plan to regain compliance with the listing requirements at such hearing.



On November 8, 2024, the Company consummated a purchase agreement with Keystone pursuant to which we may sell and issue, and Keystone is obligated to purchase, up to $20.6 million of shares of Common Stock, subject to certain market conditions. The price of the shares purchased by Keystone under the ELOC is 90% of various volume-weighted average price (“VWAP”) and closing price-based formulae, and requires a waiver, should the selling price be below $0.01 per share.



On November 11. 2024, the Company’s stockholders approved a reverse stock split ranging from 1:25 to 1:150. On November 15, 2024, the Board of Directors authorized a reverse stock split ratio of 1:40, such reverse split is anticipated to be effective on or about December 2, 2024. Although such reverse stock split is expected to enable regaining compliance with the Bid Price Requirement, it is not intended to contribute to regaining compliance with the other Requirements.
👍️0
pinkslipjunkie pinkslipjunkie 2 days ago
On 10/18/24 DEF 14 A special meeting announcement for 11/11/24, the R/S is proposal no.1: https://www.otcmarkets.com/filing/html?id=17902016&guid=T8Y-kWV46v3Th3h
However, I looked on all 8-Ks and even the 10-Q after November 11, 2024 and I never seen anywhere what the results were nor could I find where the meeting was cancelled.
👍️0
Butchmass Butchmass 2 days ago
Are we headed for a R/S ? I certainly hope not. I know a lot of insiders have recently bought in here.

Your thoughts?
👍️0
georgie18 georgie18 3 days ago
CERO...Added 079s here...🥳Trying to get another flip...
👍️0
georgie18 georgie18 5 days ago
CERO...106...🥳...Took some for a flip...

georgie18

Member Level
Re: None

Friday, December 06, 2024 10:33:11 AM

Post#
667048
of 667240
CERO...13...-30%...Bidding .10/.11...Range if I can get some for a quick flip...🥳R/S coming here and Offering...
👍️0
georgie18 georgie18 1 week ago
CERO...13...-30%...Bidding .10/.11...Range if I can get some for a quick flip...🥳
👍️0
georgie18 georgie18 1 week ago
Read the filing first...🥳...https://www.otcmarkets.com/filing/html?id=17958534&guid=lzY-kaseQ9GaJth
👍️0
BurgerKing82 BurgerKing82 2 weeks ago
????
👍️0
glenn1919 glenn1919 2 weeks ago
CERO...............https://stockcharts.com/h-sc/ui?s=CERO&p=W&b=5&g=0&id=p86431144783
👍️0
MrFishin MrFishin 2 weeks ago
Any thoughts on this one? I'm in Theralase Technologies which is a similar cancer treatment stock. Was thinking of jumping into Cero as well.
👍️0
The Night Stalker The Night Stalker 3 weeks ago
nice
👍️0
The Night Stalker The Night Stalker 3 weeks ago
NICE
👍️ 1
nothing-but-patience nothing-but-patience 4 weeks ago
Anyone buying warrants here? CEROW
👍️0
boston127 boston127 4 weeks ago
2 posts in 7 years.

Not taking you too seriously. Hey, life is good when we are making $$. Please fell free to PM me all tips, as I always do my DD on any recommendation made in good faith.
👍️0
glenn1919 glenn1919 4 weeks ago
CERO.............................https://stockcharts.com/h-sc/ui?s=CERO&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 4 weeks ago
Your very welcome...Happy you made great trades off my call...🥳
👍️0
Godric Godric 4 weeks ago
I for one can vouch for Georgie, solid chart reading and sound advice. I sold previously because he posted about the R/S etc. which saved me quite a bit of money. I also bought in on the low after the news as well. Can confirm I bought in at .23 per share. Sold it staggered all the way up to .40. Wasn't sure how high we would get. Wins a win though. 

Georgie you're awesome. Thanks for doing what you do 🙏
👍️0
Timing101 Timing101 4 weeks ago
$CERO This could move , consolidating now , was just in the $1.00 + range less than six months ago. Close Green today and then clear that .37 range off it goes.
News strong out today . FDA Clearance to move forward. https://finance.yahoo.com/news/cero-therapeutics-inc-receives-fda-134500755.html
👍️0
georgie18 georgie18 4 weeks ago
Just because your not interested doesn't matter to me...There are many of my followers that are interested...I am not bragging... just posting what I did because people ask me too...

If you paid attention I posted this at .08 range and because of the offering that CERO filed for millions of shares and the announcement of a REVERSE SPLIT ...I sold my shares for a nice profit in the .30 range...

This morning I bought back in PRE MARKET at the .21 range and sold in the 38/39 range for a flip on this morning NEWS which posted at 8:45...and I posted that so my followers would know that I am not holding...

I know all about the NEWS ...and I know all about the dilution coming because of the offering...and also the REVERSE SPLIT that's coming...and for those reasons I am not holding any shares...

I don't give a rats ass if you believe me or not...but for my followers that trust my trades and have made huge amounts of profit on my calls...my posts are helpful...

You have a great day...🥳
👍️ 1
georgie18 georgie18 4 weeks ago
News hit CERO at 8:45 in pre market...It was .18 range at that time where it closed the day before and proceeded to run into the .30s...Before you make accusations check the facts...🥳
👍️0
boston127 boston127 4 weeks ago
The low of the day was .26.

Including premarket. It opened at 33. But, you somehow bought at 21? Yeah, right!
👍️0
boston127 boston127 4 weeks ago
I'm confused. Why post your one day trades?

I have no interest. I'm here for the long term. The company may have a solution to ovarian cancer, and you are bragging about your buys at the low of the day, and your sales at the high of one day? Not interested and do not believe you.
👍️0
glenn1919 glenn1919 4 weeks ago
CERO.......................https://stockcharts.com/h-sc/ui?s=CERO&p=W&b=5&g=0&id=p86431144783
👍️0
georgie18 georgie18 4 weeks ago
CERO...All out at .38/39...from .21s this morning...🥳

georgie18

Member Level
Re: georgie18 post# 664663

Friday, November 15, 2024 8:47:58 AM

Post#
665102
of 665112
CERO...21s clearing here...Back in on News for a flip...🥳
👍️0
georgie18 georgie18 4 weeks ago
CERO...21s clearing here...Back in on News for a flip...🥳
👍️0
boston127 boston127 4 weeks ago
Any progress against the Silent Killer

is worth billions. Ovarian cancer is horrible, as healthy patients do not find out about it until it is too late. Ovarian cancer develops when abnormal cells within the ovaries begin to grow and multiply uncontrollably, forming a tumor. There are very vague symptoms in early stages, making detection difficult. I'm here for the long term.
👍️0
boston127 boston127 4 weeks ago
The bank will be made here soon.

We have just begun to run. No snake oil company here. Looking for a major run within the next 90 days.
👍️0
Crappie1979 Crappie1979 1 month ago
yes it is
👍️0
boston127 boston127 1 month ago
Nice comeback today.

Wish I bought today when it was low.
👍️0
1-1 is 4 1-1 is 4 1 month ago
The President-elect has said he wants Robert F. Kennedy Jr. to be part of his health care team, and psychedelics are at the top of a list of things, including raw milk, chelating compounds and sunshine, Kennedy alleges the Food and Drug Administration is keeping away from Americans. By ERIN SCHUMAKER, DANIEL PAYNE, RUTH READER and CARMEN PAUN 11/11/2024 02:00 PM EST
👍️0
georgie18 georgie18 1 month ago
Maybe...🥳
👍️0
zendeli1 zendeli1 1 month ago
restart soon
👍️0
georgie18 georgie18 1 month ago
CERO...Just saw this...🥳...so out for now with a nice profit...https://www.otcmarkets.com/filing/html?id=17958534&guid=lzY-kaseQ9GaJth
👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: CONGRATS, Dude!!! (THAT's how ya fluck with these Snake-Oil-Pharma firms!!! Ya make bank off of THEM, before they make bank off of YOU!!!)
👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: This (Homeopathy) snake oil stock will Close RED today!!! (Mark it!!!)
👍️0
Invest-in-America Invest-in-America 1 month ago
NO they are NOT, Sir!!! And indeed, THAT is why there has been NO FRICKIN' CURE for ANY form of Cancer on this stupid Planet for circa 7,000-years of so-called "CIVILIZATION"!!! (The ONLY way Cancers can be cured is vis-a-vis RE-EDITING the extant GENOMES of patients' Cancer cells THEMSELVES!!! And NOT by attempting to KILL those defective Cancer cells!!!)
👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: One last warning --- take you profits and RUN!!! (LEAD METAL --- of any fashion ---has NO place in the Human BODY, nor in PAINT, nor in the ENVIRONMENT, & will soon be forbidden even in lead FISHING weights!!!)
👍️0
1-1 is 4 1-1 is 4 1 month ago
Current chemotherapy ingredients include mustard gas, a known carcinogen. Cancer causing chemicals are used to treat cancer.
👍️0
hondaboost hondaboost 1 month ago
CERO,great run. Bought tons at $0.08.
👍️0
georgie18 georgie18 1 month ago
CERO...33s clearing here...Next stop .80s if this volume sticks...🥳

CERO...28s clearing here...🥳

CERO...2178...Off my .08 Alert...🥳Holding and bidding the open gap...🥳

georgie18

Member Level
Re: georgie18 post# 181

Monday, November 11, 2024 2:09:32 PM

Post#
186
of 196
CERO...179...Bidding the Gap .07 to .14...🥳Alerted at .08 Range and ran to .23 range...
👍️ 1
georgie18 georgie18 1 month ago
CERO...28s clearing here...🥳

CERO...2178...Off my .08 Alert...🥳Holding and bidding the open gap...🥳

georgie18

Member Level
Re: georgie18 post# 181

Monday, November 11, 2024 2:09:32 PM

Post#
186
of 196
CERO...179...Bidding the Gap .07 to .14...🥳Alerted at .08 Range and ran to .23 range...
👍️0
georgie18 georgie18 1 month ago
CERO...2178...Off my .08 Alert...🥳Holding and bidding the open gap...🥳

georgie18

Member Level
Re: georgie18 post# 181

Monday, November 11, 2024 2:09:32 PM

Post#
186
of 196
CERO...179...Bidding the Gap .07 to .14...🥳Alerted at .08 Range and ran to .23 range...
👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: More by "Copilot", regarding the DIFFERENCE between CERO's (fluff-news) "Animal MODEL", vs. legitimate & substantive "Animal STUDIES" ---

"However, can such a Human Pharma research company produce an "ANIMAL MODEL" without having conducted any actual "ANIMAL STUDIES"? I.e., can said company merely be referring to their THEORETICAL concepts for FUTURE actual animal STUDIES & EXPERIMENTS, without having acutally done such studies, etc.? Yes, a pharmaceutical company can indeed refer to an "animal model" in a theoretical context without having conducted actual animal studies. They might outline the animal model they intend to use based on existing knowledge or previous research. This can include describing the species, genetic modifications, or other characteristics that make the animal suitable for studying a particular disease.However, to claim progress or make definitive statements about the efficacy or safety of a drug, actual animal studies and experiments are necessary. These studies provide the empirical data needed to move forward in the drug development process, including eventual human trials. So, while a company can theoretically discuss their planned animal models, the actual validation of those models requires conducting the animal studies. Does that help clarify things for you?"
👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: Are you, UNDER PRESSURE?????

👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: Below is Bing's "Copilot" for your EDIFICATION regarding this conspicuously-SCAMMING, stinky pinky "company" ---

"What was the name of the influential 'health care' movement of the 20th Century that advocated the consumption of tiny doses of well-known POISONS & TOXIC METALS LIKE LEAD as a cure for all manner of deadly diseases? The influential health care movement you're referring to is likely Homeopathy. Developed in the late 18th century by Samuel Hahnemann, Homeopathy is based on the principle of 'like cures like' and the use of highly diluted substances to treat various ailments. While modern Homeopathy typically uses extremely diluted substances, some historical practices involved the use of tiny doses of known poisons and toxic metals, believing that these could stimulate the body's healing processes. Homeopathy remains a controversial topic in the medical community, with debates about its efficacy and scientific basis. Do you have any specific interest in homeopathy or its history?"
👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: This CERO stinky stock --- & its LEAD-based Cancer concoction --- is now headed to a ZERO!!!!

👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: Below is WHERE this goes "AH", Bro!!!! (But they sure had great news about their TEST TUBE findings!!! Heck, "NO TOXICITY" to the TEST TUBES!!! Remember, they said "ANIMAL MODEL" --- and not, "ANIMAL STUDIES"!!!)

👍️0
Invest-in-America Invest-in-America 1 month ago
CERO: Someone just dumped a TRUCK LOAD of this LEAD-lined snake oil firm!!!
👍️0

Your Recent History

Delayed Upgrade Clock